{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:54:31Z","timestamp":1787068471475,"version":"build-2736575974"},"reference-count":43,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,1,19]]},"abstract":"<jats:p>Background: Specialized pro-resolving mediators (SPMs) are bioactive lipids derived from n-3 and n-6 polyunsaturated fatty acids. SPMs promote resolution of inflammation and are reduced in Alzheimer\u2019s disease. It is unknown whether SPMs are associated with post-stroke cognitive impairment (PSCI). Objective: In the present report, we aimed to study the levels of SPMs in PSCI patients in the acute phase of ischemic stroke. Methods: Levels of SPMs in the plasma from 36 patients with PSCI and 33 patients with post-stroke non-cognitive impairment (PSNCI) were measured by enzyme immunoassay. Results: We found that levels of the SPM lipoxin A4 (LXA4) were significantly reduced in PSCI patients compared with PSNCI patients. Interestingly, the LXA4 levels were positively correlated with Mini-Mental State Examination scores, but not with the National Institutes of Health Stroke Scale scores. Such alteration and correlation were not found in any of the other SPMs analyzed, i.e., including resolvin D1, resolvin D2, and maresin 1. Conclusion: We conclude that the plasma levels of LXA4 were reduced in PSCI patents in the acute phase of ischemic stroke and were correlated to cognitive function.<\/jats:p>","DOI":"10.3233\/jad-201050","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T12:43:24Z","timestamp":1608036204000},"page":"607-613","source":"Crossref","is-referenced-by-count":16,"title":["Reduced Levels of Plasma Lipoxin A4 Are Associated with Post-Stroke Cognitive Impairment"],"prefix":"10.1177","volume":"79","author":[{"given":"Xiuzhe","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Schultzberg","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-201050_ref1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2019.07.018","article-title":"Multicenter Alzheimer\u2019s and Parkinson\u2019s disease immune biomarker verification study","volume":"16","author":"Brosseron","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201050_ref2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00415-008-0737-6","article-title":"Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer\u2019s disease and frontotemporal lobar degeneration","volume":"255","author":"Galimberti","year":"2008","journal-title":"J Neurol"},{"key":"10.3233\/JAD-201050_ref3","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-201050_ref4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0306-4522(94)90398-0","article-title":"Induction of immune system mediators in the hippocampal formation in Alzheimer\u2019s and Parkinson\u2019s diseases: Selective effects on specific interleukins and interleukin receptors","volume":"61","author":"Araujo","year":"1994","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-201050_ref5","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1038\/tp.2011.27","article-title":"Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer\u2019s disease brain","volume":"1","author":"Rao","year":"2011","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-201050_ref6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1080\/00207450701392068","article-title":"Cytokines in Alzheimer\u2019s disease and vascular dementia","volume":"118","author":"Angelopoulos","year":"2008","journal-title":"Int J Neurosci"},{"key":"10.3233\/JAD-201050_ref7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","article-title":"Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer\u2019s disease","volume":"117","author":"Bermejo","year":"2008","journal-title":"Immunol Lett"},{"key":"10.3233\/JAD-201050_ref8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jns.2008.05.020","article-title":"Markers of endothelial dysfunction in older subjects with late onset Alzheimer\u2019s disease or vascular dementia","volume":"272","author":"Zuliani","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-201050_ref9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.3233\/JAD-201050_ref10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: Endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.3233\/JAD-201050_ref11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive lipids and chronic inflammation: Managing the fire within","volume":"9","author":"Chiurchiu","year":"2018","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-201050_ref12","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1038\/s41467-019-11928-w","article-title":"Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson\u2019s disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-201050_ref13","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3324\/haematol.2019.219519","article-title":"Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction","volume":"105","author":"Kooij","year":"2020","journal-title":"Haematologica"},{"key":"10.3233\/JAD-201050_ref14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","article-title":"Resolution of inflammation is altered in Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-201050_ref15","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.ajpath.2013.01.051","article-title":"Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice","volume":"182","author":"Medeiros","year":"2013","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-201050_ref16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/JAD-141335","article-title":"Restoration of lipoxin A4 signaling reduces Alzheimer\u2019s disease-like pathology in the 3xTg-AD mouse model","volume":"43","author":"Dunn","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-201050_ref17","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-201050_ref18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/ene.13191","article-title":"Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack","volume":"24","author":"Arba","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-201050_ref19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1186\/s13063-020-04656-w","article-title":"Evaluation of the efficacy and safety of the use of acupuncture for the adjuvant treatment of patients with post-stroke cognitive impairment: Protocol for a randomized controlled trial","volume":"21","author":"Liu","year":"2020","journal-title":"Trials"},{"key":"10.3233\/JAD-201050_ref20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41467-018-03674-2","article-title":"Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer\u2019s disease","volume":"9","author":"Lee","year":"2018","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-201050_ref21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbrc.2011.04.013","article-title":"Lipoxin A4 inhibits the production of proinflammatory cytokines induced by \u03b2-amyloid in vitro and in vivo","volume":"408","author":"Wu","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-201050_ref22","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","article-title":"Pro-resolving lipid mediators improve neuronal survival and increase Abeta42 phagocytosis","volume":"53","author":"Zhu","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-201050_ref23","doi-asserted-by":"crossref","first-page":"e00688","DOI":"10.1002\/brb3.688","article-title":"Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery","volume":"7","author":"Hawkins","year":"2017","journal-title":"Brain Behav"},{"key":"10.3233\/JAD-201050_ref24","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1096\/fj.14-263160","article-title":"Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke","volume":"29","author":"Smith","year":"2015","journal-title":"FASEB J"},{"key":"10.3233\/JAD-201050_ref25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jnc.12607","article-title":"Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic stroke","volume":"129","author":"Hawkins","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-201050_ref26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1179\/1743132813Y.0000000242","article-title":"Lipoxin A4 ameliorates cerebral ischaemia\/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2","volume":"35","author":"Wu","year":"2013","journal-title":"Neurol Res"},{"key":"10.3233\/JAD-201050_ref27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12031-011-9620-5","article-title":"A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury","volume":"46","author":"Wu","year":"2012","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-201050_ref28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12031-010-9355-8","article-title":"Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia","volume":"42","author":"Wu","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-201050_ref29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.01.079","article-title":"Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion","volume":"1323","author":"Ye","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-201050_ref30","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1523\/JNEUROSCI.5529-08.2009","article-title":"Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPAR-\u03b3-dependent, neuroprotective effects of rosiglitazone in experimental stroke","volume":"29","author":"Sobrado","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-201050_ref31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s12031-020-01533-8","article-title":"Post-stroke cognitive impairment: A review focusing on molecular biomarkers","volume":"70","author":"Zhang","year":"2020","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-201050_ref32","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.02.004","article-title":"Cytokine response, tract-specific fractional anisotropy, and brain morphometry in post-stroke cognitive impairment","volume":"27","author":"Kulesh","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.3233\/JAD-201050_ref33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/ijs.12001","article-title":"Inflammatory markers and their association with post stroke cognitive decline","volume":"10","author":"Narasimhalu","year":"2015","journal-title":"Int J Stroke"},{"key":"10.3233\/JAD-201050_ref34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0891988710373598","article-title":"The relationship between inflammatory markers and post stroke cognitive impairment","volume":"23","author":"Rothenburg","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-201050_ref35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbi.2020.03.011","article-title":"AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice","volume":"87","author":"Kim","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-201050_ref36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/WNR.0000000000001489","article-title":"Targeting NLRP3 inflammasome improved the neurogenesis and post-stroke cognition in a mouse model of photothrombotic stroke","volume":"31","author":"Li","year":"2020","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-201050_ref37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12975-019-00752-5","article-title":"Delayed administration of angiotensin II type 2 receptor (AT2R) agonist compound 21 prevents the development of post-stroke cognitive impairment in diabetes through the modulation of microglia polarization","volume":"11","author":"Jackson","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.3233\/JAD-201050_ref38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12974-020-01815-3","article-title":"Microglia knockdown reduces inflammation and preserves cognition in diabetic animals after experimental stroke","volume":"17","author":"Jackson","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-201050_ref39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1183\/09031936.00106013","article-title":"Reduced 15-lipoxygenase 2 and lipoxin A4\/leukotriene B4 ratio in children with cystic fibrosis","volume":"44","author":"Ringholz","year":"2014","journal-title":"Eur Respir J"},{"key":"10.3233\/JAD-201050_ref40","doi-asserted-by":"crossref","first-page":"e13206","DOI":"10.1111\/aji.13206","article-title":"Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma","volume":"83","author":"Oliveira Perucci","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"10.3233\/JAD-201050_ref41","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/2047487317694464","article-title":"Low salivary resolvin D1 to leukotriene B4 ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation","volume":"24","author":"Thul","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.3233\/JAD-201050_ref42","doi-asserted-by":"crossref","first-page":"12859","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-201050_ref43","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-201050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:39Z","timestamp":1777370679000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-201050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":43,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-201050","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}